Moreover, activation of the HIF‐1α/SLC7A11 pathway exerts anti‐ferroptosis effects [29], and HIF‐1α is the main inducer of hypoxia‐induced ferroptosis resistance [30], as well as an indicator of immunotherapy sensitivity in PCa [31]. The gene discussed is HIF1A; the disease is posterior cortical atrophy.